Condensed Consolidated Statements of Shareholders' (Deficit) Equity - USD ($) $ in Thousands	Total	CFPI	PIPE Agreement	Common Shares	Common Shares CFPI	Common Shares PIPE Agreement	Additional Paid in Capital	Additional Paid in Capital CFPI	Additional Paid in Capital PIPE Agreement	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Stockholders' equity, beginning of period at Dec. 31, 2020	$ (46,596)			$ 36			$ 105,835			$ (294)	$ (152,173)
Stockholders' equity, beginning of period (in shares) at Dec. 31, 2020				36,463,696
Increase (Decrease) in Stockholders' Equity
Debt discount related to beneficial conversion feature of convertible loan notes	19,645						19,645
Unrealized gain (loss) on foreign currency translation	(571)									(571)
Net income (loss)	(102,357)										(102,357)
Stockholders' equity, end of period at Mar. 31, 2021	(129,879)			$ 36			125,480			(865)	(254,530)
Stockholders' equity, ending of period (in shares) at Mar. 31, 2021				36,463,696
Stockholders' equity, beginning of period at Dec. 31, 2020	(46,596)			$ 36			105,835			(294)	(152,173)
Stockholders' equity, beginning of period (in shares) at Dec. 31, 2020				36,463,696
Increase (Decrease) in Stockholders' Equity
Unrealized gain (loss) on foreign currency translation	2,505
Net income (loss)	(122,974)
Stockholders' equity, end of period at Sep. 30, 2021	(123,019)			$ 41			149,876			2,211	(275,147)
Stockholders' equity, ending of period (in shares) at Sep. 30, 2021				36,792,417
Stockholders' equity, beginning of period at Mar. 31, 2021	(129,879)			$ 36			125,480			(865)	(254,530)
Stockholders' equity, beginning of period (in shares) at Mar. 31, 2021				36,463,696
Increase (Decrease) in Stockholders' Equity
Debt discount related to beneficial conversion feature of convertible loan notes	11,644						11,644
Unrealized gain (loss) on foreign currency translation	255									255
Net income (loss)	254										254
Stockholders' equity, end of period at Jun. 30, 2021	(117,726)			$ 36			137,124			(610)	(254,276)
Stockholders' equity, ending of period (in shares) at Jun. 30, 2021				36,463,696
Increase (Decrease) in Stockholders' Equity
Debt discount related to beneficial conversion feature of convertible loan notes	2,821									2,821
Conversion of advanced subscription into ordinary shares	12,757			$ 5			12,752
Conversion of advanced subscription into ordinary shares (in shares)				328,721
Unrealized gain (loss) on foreign currency translation	2,821
Net income (loss)	(20,871)										(20,871)
Stockholders' equity, end of period at Sep. 30, 2021	(123,019)			$ 41			149,876			2,211	(275,147)
Stockholders' equity, ending of period (in shares) at Sep. 30, 2021				36,792,417
Stockholders' equity, beginning of period at Dec. 31, 2021	$ 47,694			$ 94			415,304			2,247	(369,951)
Stockholders' equity, beginning of period (in shares) at Dec. 31, 2021	93,950,205			93,950,205
Increase (Decrease) in Stockholders' Equity
Issuance of common shares	$ 3,000			$ 1			2,999
Issuance of common shares pursuant to (in shares)				715,991
Share-based compensation expense	996						996
Unrealized gain (loss) on foreign currency translation	2,983									2,983
Net income (loss)	(40,342)										(40,342)
Stockholders' equity, end of period at Mar. 31, 2022	14,331			$ 95			419,299			5,230	(410,293)
Stockholders' equity, ending of period (in shares) at Mar. 31, 2022				94,666,196
Stockholders' equity, beginning of period at Dec. 31, 2021	$ 47,694			$ 94			415,304			2,247	(369,951)
Stockholders' equity, beginning of period (in shares) at Dec. 31, 2021	93,950,205			93,950,205
Increase (Decrease) in Stockholders' Equity
Unrealized gain (loss) on foreign currency translation	$ 17,710
Net income (loss)	(127,201)
Stockholders' equity, end of period at Sep. 30, 2022	$ (33,638)			$ 109			443,448			19,957	(497,152)
Stockholders' equity, ending of period (in shares) at Sep. 30, 2022	108,593,517			108,593,517
Stockholders' equity, beginning of period at Mar. 31, 2022	$ 14,331			$ 95			419,299			5,230	(410,293)
Stockholders' equity, beginning of period (in shares) at Mar. 31, 2022				94,666,196
Increase (Decrease) in Stockholders' Equity
Issuance of common shares	3,278			$ 2			3,276
Issuance of common shares pursuant to (in shares)				1,659,316
Share-based compensation expense	1,695						1,695
Unrealized gain (loss) on foreign currency translation	9,826									9,826
Net income (loss)	(55,393)										(55,393)
Stockholders' equity, end of period at Jun. 30, 2022	(26,263)			$ 97			424,270			15,056	(465,686)
Stockholders' equity, ending of period (in shares) at Jun. 30, 2022				96,325,512
Increase (Decrease) in Stockholders' Equity
Issuance of common shares		$ 1,239	$ 13,803		$ 1	$ 11		$ 1,238	$ 13,792
Issuance of common shares pursuant to (in shares)					938,864	11,329,141
Issuance of warrants related to PIPE agreement	1,894						1,894
Share-based compensation expense	2,254						2,254
Unrealized gain (loss) on foreign currency translation	4,901									4,901
Net income (loss)	(31,466)										(31,466)
Stockholders' equity, end of period at Sep. 30, 2022	$ (33,638)			$ 109			$ 443,448			$ 19,957	$ (497,152)
Stockholders' equity, ending of period (in shares) at Sep. 30, 2022	108,593,517			108,593,517